Ferrer (Grupo Ferrer Internacional SA) is a private, international pharmaceutical company headquartered in Barcelona, Spain. Founded in 1959, the company specializes in the research, development, manufacturing, and commercialization of therapeutic solutions for serious and debilitating diseases.

Core Business & Focus Areas

Ferrer operates across the entire pharmaceutical value chain, including fine chemicals development, manufacturing, and international marketing. Their primary therapeutic areas of focus include:

Pulmonary Vascular and Interstitial Lung Diseases:
Addressing conditions like pulmonary hypertension and progressive supranuclear palsy (PSP).

Neurological Disorders:
Developing treatments for diseases with cerebral or spinal cord components, such as Parkinson’s, epilepsy, and motor neuron disorders.

Specialized and Hospital Products:
Providing a range of medicines, food supplements, diagnostics, and over-the-counter (OTC) self-care products.
“Ferrer for Good” Mission

A distinctive aspect of Ferrer is its mission, “Ferrer for Good,” which positions the company as an activist for social justice, using its business as a force for positive change. As the highest-rated pharmaceutical B Corp in the world, the company has committed to reinvesting a significant portion of its profits into social and environmental initiatives. This commitment is structured around three strategic pillars:

Great People:
Fostering a people-centered culture focused on employee well-being and talent development.

Liveable Planet:
Promoting environmental preservation through sustainable practices, such as using 100% renewable electricity and achieving high rates of waste recovery.

Collective Action:
Collaborating externally to address critical societal challenges.

With over 1,800 employees and a presence in more than 100 countries, Ferrer is a global entity that maintains a strong commitment to quality, ethics, and sustainability in the healthcare sector.